Kenichi Nishimura
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
An N-terminal CDC42 T43I variant reveals the mechanism of pyrin inflammasome activation.
Journal: Science immunology
Published: August 07, 2026
TeMPRA: advancing continuing professional development in pediatric rheumatology in Japan.
Journal: Pediatric rheumatology online journal
Published: May 16, 2025
The first nationwide epidemiological survey of chronic recurrent multifocal osteomyelitis in Japan.
Journal: Modern rheumatology
Published: February 06, 2025
Clinical characteristics and treatment strategies for A20 haploinsufficiency in Japan: a national epidemiological survey.
Journal: Frontiers in immunology
Published: December 19, 2024
Recommendations for the treatment of juvenile idiopathic arthritis with oligoarthritis or polyarthritis from the 2024 update of the Japan College of Rheumatology Clinical Practice Guidelines for the management of rheumatoid arthritis including juvenile idiopathic arthritis with oligoarthritis or polyarthritis - secondary publication.
Journal: Modern rheumatology
Published: October 21, 2024
Intolerance of oral methotrexate in juvenile idiopathic arthritis.
Journal: Pediatrics international : official journal of the Japan Pediatric Society
Published: September 10, 2024
Systematic review and meta-analysis for the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis.
Journal: Modern rheumatology
Published: March 05, 2024
Efficacy and safety of abatacept for systemic juvenile idiopathic arthritis: A systematic review.
Journal: Modern rheumatology
Published: February 05, 2024
Severe RAS-Associated Lymphoproliferative Disease Case with Increasing αβ Double-Negative T Cells with Atypical Features.
Journal: Journal of clinical immunology
Published: May 31, 2023
Clinical Characteristics of Cryopyrin-Associated Periodic Syndrome and Long-Term Real-World Efficacy and Tolerability of Canakinumab in Japan: Results of a Nationwide Survey.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 04, 2023
Last Updated: 09/26/2026